"MabCure Inc. (MBCI) - Product Pipeline Analysis" Now Available at Fast Market Research
MabCure Inc. (MabCure) is a biotechnology company, based in the US. The company develops monoclonal antibodies for the in-vitro diagnostic markets. It develops novel molecular antibodies as diagnostic tools for the detection of prostate and ovarian cancers at an early stage. The company also develops new technologies for the early detection of cancer as well antibodies and drugs that attacks on cancer cells. The company uses its cancer-specific molecular antibodies in three additional areas, namely, the imaging of cancer, immunotherapy...
View full press release